3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Myelodysplastic Syndromes
5
Lymphoma, Non-Hodgkin
5
Leukemia
5
Hodgkin Disease
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myeloid, Acute
4
Leukemia, Myeloid, Accelerated Phase
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Neoplasms, Plasma Cell
3
Multiple Myeloma
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Graft vs Host Disease
3
Congenital Abnormalities
3
Recurrence
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Myasthenia Gravis
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, B-Cell, Marginal Zone
2
Immunoblastic Lymphadenopathy
2
Hematologic Neoplasms
2
Dendritic Cell Sarcoma, Interdigitating
2
Burkitt Lymphoma
2
Blast Crisis
2
Interventions
Ursodeoxycholic Acid
1
Steroids
1
Spermine Synthase
1
Prednisone
1
Mycophenolic Acid
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone
1
Liquid Biopsy
1
Clinical Protocols
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Hepatitis
×
Mycophenolic Acid
×
Clear all
NCT04810156
2022-12-14
I-HEP
Herlev Hospital
Phase 2
Unknown
60 enrolled